NCAM1 and gastric cancer: Based on the obtained results, we noticed a statistically significant decrease in the percentage of NK cells CD3-CD16+CD56+ and classical monocytes CD14+CD16- in patients diagnosed with gastric cancer compared to patients in the control group (Table 1).